1                                 Symptoms and colposcopic abnormalities were rare.

2 l women with any cytological abnormality for colposcopic assessment, but postponed treatment until th

3 -1998, 4948 monolayer cytologic slides, 2237 colposcopic biopsies, and 535 LEEP specimens were interp

4 esent should become the standard practice of colposcopic biopsy.

5                                              Colposcopic, cytologic, and HPV testing were performed o

6 dular cells should be referred for immediate colposcopic evaluation.

7                          Microbiological and colposcopic evaluations indicate that the apertured film

8 , all evidence from both microbiological and colposcopic evaluations indicates that the apertured fil

9 f cervical precancer in vivo during clinical colposcopic examination.

10 324 additional Papanicolaou tests and 11,502 colposcopic examinations in women 45 to 59 years of age.

11  number of additional Papanicolaou tests and colposcopic examinations that would be required to avert

12 9,665 additional Papanicolaou tests and 3861 colposcopic examinations would be needed in women 30 to

13 emic area in Madagascar underwent pelvic and colposcopic examinations.

14 uencing data were correlated to cytology and colposcopic findings.

15 Risk of 2-year cumulative CIN3+, viral load, colposcopic impression, and age were compared between di

16 SIL was observed for women with a high-grade colposcopic impression, HSIL cytology, and human papillo

17 om distinct acetowhite lesions and ranked by colposcopic impression.

18   Intercourse was not associated with gross, colposcopic, or histologic vaginal epithelial abnormalit

19 ers (all 12 cancers were HPV-positive), with colposcopic referral of 12.3% of women.

20                 These were compared with the colposcopic results.